Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-19 Purchase | 2023-09-20 06:15 am | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Partners X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners VII LLC ARCH Venture Partners VII L.P. ARCH Venture Fund VII L.P. ARCH Venture Partners VIII LLC ARCH Venture Fund VIII Overage L.P. 10% Owner | 1,500,000 | $17 | $25,500,000 | 3,624,143 (Indirect) | View |
| 2020-12-22 Purchase | 2020-12-22 8:28 pm | 908 Devices Inc. | MASS | ARCH Venture Fund VII L.P. ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC BYBEE CLINTON NELSEN ROBERT 10% Owner | 300,000 | $20 | $6,000,000 | 5,725,045 (Direct) | View |
| 2019-07-15 Sale | 2019-07-17 7:26 pm | Syros Pharmaceuticals Inc. | SYRS | ARCH Venture Fund VII L.P. ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner | 63,000 | $7.7664 | $489,280 | 4,242,051 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion